Evidence map›Paper›PMID 35044827›Full record

ArticleScience advances2022

Class I histone deacetylases (HDAC1-3) are histone lysine delactylases.

Carlos Moreno-Yruela, Di Zhang, Wei Wei, Michael Bæk, Wenchao Liu, Jinjun Gao, Daniela Danková, Alexander L Nielsen, Julie E Bolding, Lu Yang and 4 more

Abstract read
In one paragraph

Article in Science advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 561 papers.

0numbers the graph read from it
0cells of the map it votes in
561citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

561 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Lactate Signal: Modulator of Cellular Energy Production and Anabolism.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Propionate promotes CD8Journal for immunotherapy of cancer · 2026
    Article
  19. Article
  20. Article

501 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Carlos Moreno-YruelaCenter for Biopharmaceuticals and Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.ORCID 0000-0003-2450-6519
Di ZhangBen May Department for Cancer Research, The University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0002-9341-9884
Wei WeiShanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, China.
Michael BækCenter for Biopharmaceuticals and Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.ORCID 0000-0001-7416-9421
Wenchao LiuBen May Department for Cancer Research, The University of Chicago, Chicago, IL 60637, USA.
Jinjun GaoBen May Department for Cancer Research, The University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0002-7390-5578
Daniela DankováCenter for Biopharmaceuticals and Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.ORCID 0000-0003-1957-3514
Alexander L NielsenCenter for Biopharmaceuticals and Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.ORCID 0000-0003-1195-0143
Julie E BoldingCenter for Biopharmaceuticals and Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.ORCID 0000-0003-2735-2519
Lu YangBen May Department for Cancer Research, The University of Chicago, Chicago, IL 60637, USA.
Samuel T JamesonCenter for Biopharmaceuticals and Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.
Jiemin WongShanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, China.ORCID 0000-0002-5311-842X
Christian A OlsenCenter for Biopharmaceuticals and Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.ORCID 0000-0002-2953-8942
Yingming ZhaoBen May Department for Cancer Research, The University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0003-1928-2151

Funding

Histone lactylation pathway in hair cycle: deacylases and their protein targetsR01AR078555 · NIAMS · UNIVERSITY OF CHICAGO · PI LIN, HENING, ZHAO, YINGMING · 2021 to 2025
$3.3M
Lactate production by tumor associated macrophages promotes tumorigenesisR01CA251677 · NCI · UNIVERSITY OF CHICAGO · PI BECKER, LEV, ZHAO, YINGMING · 2021 to 2025
$2.8M
Biochemistry of the lysine beta-hydroxybutyrylation pathwayR01DK118266 · NIDDK · UNIVERSITY OF CHICAGO · PI COLE, PHILIP A, ZHAO, YINGMING · 2018 to 2021
$2.1M
Systematic screening for new histone marks and studying their epigenetic functionR01GM135504 · NIGMS · UNIVERSITY OF CHICAGO · PI ZHAO, YINGMING · 2020 to 2023
$2.1M
NCI NIH HHS R01 CA251677NIAMS NIH HHS R01 AR078555NIDDK NIH HHS R01 DK118266NIGMS NIH HHS R01 GM135504
6 · The paper itself

Abstract

Lysine L-lactylation [K(L-la)] is a newly discovered histone mark stimulated under conditions of high glycolysis, such as the Warburg effect. K(L-la) is associated with functions that are different from the widely studied histone acetylation. While K(L-la) can be introduced by the acetyltransferase p300, histone delactylases enzymes remained unknown. Here, we report the systematic evaluation of zinc- and nicotinamide adenine dinucleotide–dependent histone deacetylases (HDACs) for their ability to cleave ε-

Indexed as

Histone DeacetylasesHistonesAcetylationLysineHistone DeacetylasesHistonesLysine

Identifiers

PMID35044827
PMCPMC8769552

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.